These aggregates not only disrupt cellular functions but also serve as a hallmark for neurodegenerative diseases, including Alzheimer’s and Huntington’s disease. Recent research, published in the ...

Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for patients suffering from Alzheimer’s disease (AD) and other ...

At age 24, Marissa Phillips balances her strict rehearsal schedule with full-time work in corporate accounting and her ...